Austria Strips Pfizer Of Lipitor Patent

Law360, New York (March 29, 2005, 12:00 AM EST) -- In a victory for Ranbaxy Pharmaceuticals, Austria’s patent office has stripped Pfizer Inc. of its patent for the blockbuster cholesterol-lowering drug Lipitor.

The U.S. drug maker’s patent was successfully challenged by India’s largest pharmaceutical company, which is also challenging the Lipitor patent in other countries, including the U.S.

Pfizer said Tuesday it would appeal the decision, which only applies to the Austrian market.

Pfizer said it was confident it would, on appeal, be able to make a compelling argument in support of its patent.

Pfizer holds...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.